Achieve Life Sciences, Inc.
ACHV · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $160,706 | $78,388 | $92,609 | $121,478 |
| - Cash | $31,930 | $51,874 | $13,016 | $12,733 |
| + Debt | $9,958 | $9,960 | $9,960 | $9,958 |
| Enterprise Value | $138,734 | $36,474 | $89,553 | $118,703 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$14,194 | -$12,472 | -$12,580 | -$12,105 |
| % Margin | – | – | – | – |
| Net Income | -$14,441 | -$12,718 | -$12,827 | -$12,360 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.28 | -0.37 | -0.37 | -0.36 |
| % Growth | 24.3% | 0% | -2.8% | – |
| Operating Cash Flow | -$11,331 | -$9,069 | -$11,088 | -$9,189 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$11,331 | -$9,069 | -$11,088 | -$9,189 |